School of Pharmaceutical Sciences, Peking University Health Science Center. The team of Prof. Luwen Shi and Prof. Xiaodong Guan has made progress in the innovation and clinical benefit evaluation of cancer drugs in China[J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(2): 156-157.